Pharmaceutical Technology6d
FDA approves Alvotech and Teva’s SELARSDI for new indications
The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the treatment of ulcerative colitis and Crohn's ...
Yahoo Finance6d
FDA approves Alvotech and Teva’s SELARSDI for new indications
The US Food and Drug Administration (FDA) has approved a new presentation of Alvotech and Teva Pharmaceuticals’ SELARSDI (ustekinumab-aekn), expanding its label to include the treatment of ...
rheumatologyadvisor4d
New Presentation, Indications Approved for Biosimilar Selarsdi
Selarsdi (ustekinumab-aekn), a biosimilar to Stelara (ustekinumab), is expanded to the indications to include treatment of Crohn disease ...
Drug Store News16h
Alvotech, Teva obtain FDA nod for new Selarsdi indication
The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include ...
Investing6d
Alvotech's SWOT analysis: biosimilar powerhouse stock faces growth hurdles
The remaining proceeds from the term loan are intended to support working capital needs and ongoing and near-term product launches, particularly for Simlandi and Selarsdi. Analysts maintain a ...
Investing6d
Alvotech's SWOT analysis: biosimilar powerhouse stock faces growth hurdles
The remaining proceeds from the term loan are intended to support working capital needs and ongoing and near-term product launches, particularly for Simlandi and Selarsdi. Analysts maintain a positive ...
dermatologyadvisor6d
New Presentation, Indications Approved for Biosimilar Selarsdi
“We are thrilled with the expansion of Selarsdi’s indications, marking another significant milestone in Teva’s commitment to increasing access to biosimilars in the US,” said Thomas Rainey, Senior ...